Quantcast
Home / Practice Areas / Business and Civil Practice / Merck to pay $12M in fees to end Vioxx suits

Merck to pay $12M in fees to end Vioxx suits

Merck & Co. agreed to settle shareholder lawsuits over the withdrawn Vioxx painkiller by strengthening its drug-safety procedures, appointing a new chief medical officer and paying $12.2 million in legal fees.